Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma

Phase 2

Completed

• Conditions: Pediatric Aphakic Glaucoma

• Registration Number: NCT00371072
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

In this randomized clinical trial we compare trabeculectomy with mitomycin-C (T+MMC) and Ahmed glaucoma implant (AGI) in treatment of aphakic glaucoma in children under 16 years of age.Complete and qualified success were defined as 5≤IOP≤21mmHg without and with medication respectively and we came to this point that; T+MMC and AGI are comparable in terms of success rate and complications in pediatric aphakic glaucoma.

Detailed Description

Not available

Study Timeline

• Status Verified: 2003-07
• Study Start: 2004-03
• Study Completion: 2005-11
• Study First Submitted: 2006-08-31
• Study First Submitted QC: 2006-08-31
• Study First Posted: 2006-09-01
• Last Update Submitted: 2006-10-06
• Last Update Posted: 2006-10-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• congenital cataract
• history of cataract surgery
• under 16 years old
• Ocular pressure more than 21 mmHg

Exclusion Criteria

• interruption of the follow up before 6 month
• Anterior segment dysgenesis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Ophthalmic Research Center; 🇮🇷 Tehran, Iran, Islamic Republic of